The QualityStocks Daily Thursday, December 12th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (BTLN) +308.16%

StockMarketWatch (ASRT) +56.65%

MarketClub Analysis (AMRX) +44.83%

The QualityStocks Daily Stock List

China Health Industries Holdings, Inc. (CHHE)

Hot OTC Stocks, Zacks, The Hot Penny Stocks, Wallmine, InvestorsHub, MarketWired, Market Screener, Proactive Investors, OTC Markets, Simply Wall St, Stockhouse, Stock Earnings, Wallet Investor, YCharts, and GuruFocus reported previously on China Health Industries Holdings, Inc. (CHHE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

China Health Industries Holdings, Inc. is a holding company vertically integrated with the operations in its subsidiaries in the People's Republic of China. It specializes in research and development (R&D), production, marketing and distribution of hemp derivative products, medicines and health supplement products. The Company has completed the strategic transformation from being a traditional health supplement products manufacturer to a hemp derivative products pioneer. OTCQB-listed, China Health Industries Holdings has its head office in Harbin, China.

The Company owns GMP certified plants and facilities. It manufactures 21 CFDA approved medicines and 14 health supplement products covering five types of dosage forms. These include soft capsule, hard capsule, tablet, granule, and oral liquid. Its product series encompass hemp derivative foods, hemp derivative medicines, externally used medicines and health foods. These products address important major markets such as women’s products, geriatric products, children’s products, and other important market sectors. Its hemp derivative products have been launched into the Chinese marketplace. This includes Hemp Oil, Hemp Protein Powder, Hemp Polypeptide as well as Hemp Cosmetics.

China Health Industries’ intention is to market much of its product line covering all of China and overseas countries. As a first step toward implementing its business plan, it strategically transferred its business to production, sales and R&D of Hemp-based products in 2018. It is working to establish sales centers and chain-stores to connect consumers closely with its products.

Recently, China Health Industries Holdings announced the financial results for its Q1 ended September 30, 2019. Mr. Xin Sun, Chief Executive Officer and Chairman of the Company, said, "We are pleased to report our financial results for the first quarter of our 2020 fiscal year. Our revenue decreased by 4.10 percent for the three months ended September 30, 2019, as compared to the same period in 2018. However, our net income increased by 19.67 percent for the three months ended September 30, 2019, as compared to the same period in 2018. We continue to focus on developing, manufacturing and distributing new hemp derivative products".

China Health Industries Holdings, Inc. (CHHE), closed Thursday's trading session at $0.55, off by 27.4789%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 548 and the stock's 52-week low/high is $0.25/$1.75.

chart

Fission Uranium Corp. (FCUUF)

Wealth Daily, Resource Stock Digest, TipRanks, Junior Mining Network, Stock News Now, Metals News, Energy and Capital, Streetwise Reports, Wallet Investor, Resource World, Stockhouse, and Zacks reported beforehand on Fission Uranium Corp. (FCUUF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Fission Uranium Corp. engages in the exploration and development of uranium properties. The Company owns the award-winning PLS (Patterson Lake South) uranium project, host to the near-surface, high-grade Triple R deposit - part of the largest mineralized trend in the Athabasca Basin region. Significant new high-grade zones have been discovered each year since discovery in 2012. Exploration drilling has encountered mineralization 600m west of the trend.

The Company is concentrating on continued exploration at the large and highly-prospective PLS project and further development of the Triple R deposit. Patterson Lake South (PLS) is host to the above-mentioned Triple R deposit - the most significant high grade shallow depth deposit in the region. The Triple R deposit is open in manifold directions, especially westwards, towards the high-grade boulder field. A preliminary economic study conducted in 2015 shows the Triple R has the potential for an OPEX of $14.02/lb. This would make it one of the world's lowest cost uranium producers.

Fission Uranium has 100 percent ownership of the PLS Property. This Property comprises 17 mineral claims totaling 31,039 ha located on the southwest margin of the Athabasca Basin. The property is accessible by all-weather Highway 955 that continues north through the area of the UEX-AREVA Shea Creek deposits to the past producing Cluff Lake uranium mine.

Fission Uranium announced in May 2019 that it filed a technical report on the Triple R Deposit at its PLS project, pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects" (NI 43-101). This Report summarizes the Pre-Feasibility Study that highlights the strong economics and long-term potential of the Triple R deposit.

Mineral Reserves were estimated for the Project, based on a hybrid (underground plus open pit) approach to production at PLS. Furthermore, the Report recognizes the potential for an underground-only approach that was completed to PEA level and shows considerable advantages. This includes lower CAPEX and shorter construction time. As a result, Fission Uranium is advancing this scenario to Prefeasibility Study stage.

Moreover, last month, Fission Uranium filed an underground-only PFS report highlighting reduced footprint, Lower CAPEX and faster construction. The Report summarizes the Pre-Feasibility Study (UG PFS) that outlines an underground-only mining scenario for PLS and follows an earlier PFS report outlining a combination of open pit and underground techniques (the Hybrid PFS).

Fission Uranium Corp. (FCUUF), closed Thursday's trading session at $0.19, off by 3.3079%, on 264,575 volume with 65 trades. The average volume for the last 3 months is 203,307 and the stock's 52-week low/high is $0.1875/$0.456699997.

chart

Jacksam Corporation (JKSM)

Otc.watch, Stockopedia, Real Investment Advice, Stockwatch, Simply Wall St, Investors Hangout, Last10k, GlobeNewswire, TradingView, Investors Hub, and PR Newswire reported earlier on Jacksam Corporation (JKSM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Jacksam Corporation is a workflow automation company focused on developing machinery and equipment solutions for the cannabis and CBD (cannabidiol) industry. The OTCQB-listed, Company designs and markets proprietary automated vape, POD and cartridge filling/capping equipment for the cannabis industry. It serves the medical cannabis, hemp, and CBD segments of the e-cigarette and vaporizer markets with its oil vaporizer focused products. Jacksam has its corporate office in Rancho Santa Margarita, California.

Jacksam’s automated equipment is designed and built in the United States. It carries the only full UL certification in the U.S. Using Jacksam/Convectium's automated equipment, its customers boost output by up to 60 times over hand filling.

Jacksam/Convectium is centered on helping its customers automate their workflow and get custom branded products onto dispensary shelves quickly. Greater than 100 companies, including many dominant brands in the space, rely on Jacksam/Convectium for automation of their filling operations.

Jacksam has adopted an “open source” business model enabling the majority of cannabis and CBD oil producers to benefit from its filling and capping equipment. Jacksam (shifting away from a closed system approach) has made its vape, POD and cartridge trays and equipment compatible with components produced by most of the leading worldwide manufacturers.

Last week, TILT Holdings, Inc. (CSE:TILT) (OTCQB:TLLTF), a foundational technology cannabis platform consisting of assets to support brands globally, announced that its subsidiary Jupiter Research, LLC, and Convectium Jacksam Corporation (JKSM), signed a memorandum of understanding (MOU) to create an exclusive proprietary cartridge and POD pre-racking solution, enabling producers and extractors to scale to meet fast growing demand. The Ultimate Automation Solution includes pre-racked Jupiter CCell® cartridge trays and Convectium’s filling and capping machines. This allows cannabis and CBD producers and extractors to save time and money by way of automatic filling and capping. TILT services greater than 2,000 brands and cannabis retailers across 33 States in the U.S., and also in Canada, Israel, Mexico, South America and the European Union (EU).

Jacksam Corporation (JKSM), closed Thursday's trading session at $0.43, up 43.3333%, on 3,746 volume with 6 trades. The average volume for the last 3 months is 2,107 and the stock's 52-week low/high is $0.280099987/$3.20000004.

chart

Origin House (ORHOF)

NetworkNewsWire, NIC Investors, PotNetwork, Wallet Investor, Stockwatch, Profit Confidential, Pot Stock News, Trading View, Midas Letter, New Cannabis Ventures, Insider Financial, Marketfy, The Seed Investor, and Investors Hub reported previously on Origin House (ORHOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A North American cannabis products and brands company, Origin House lists on the OTC Markets’ OTCQX. The Company (formerly known as CannaRoyalty Corp.) specializes in acquisitions. It is developing infrastructure to support the proliferation of its brands around the world, initially through its acquisition of Canadian retailer 180 Smoke. Origin House operates across key markets in the United States and Canada. The Company’s strategic emphasis is on becoming a preeminent global house of cannabis brands. Origin House is headquartered in Ottawa, Ontario.

Origin House's foundation is in California, where it delivers in excess of 130 branded cannabis products from 50-plus brands to the majority of licensed dispensaries. The Company’s brand development platform is operated out of six licensed facilities located throughout California, and provides distribution, manufacturing, cultivation and marketing services for its brand partners.

The Company has a strong distribution network, bringing brands to over 400 retailers. It sees strong revenue from owned and distributed brands. Origin House states that it is building a portfolio of California brands that will be in demand worldwide. While seeing strong revenue from owned and distributed brands in California, its acquired brands build its position for wider growth.

CannaRoyalty Corp. d/b/a Origin House announced this past June that it obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving the plan of arrangement with Cresco Labs, Inc. earlier announced on April 1, 2019 , pursuant to which, among other things, Cresco Labs intends to acquire all of the issued and outstanding common shares and class A compressed shares of Origin House. Receipt of the final order will allow Origin House to complete the Arrangement upon satisfaction of the remaining closing conditions. This includes the receipt of required regulatory approvals.

In October, CannaRoyalty Corp. d/b/a Origin House announced that it attained full integration with the California Cannabis Track-and-Trace (CCTT) system at each of its six licensed facilities in the State. The CCTT system, developed by software vendor, Metrc, uses RFID-enabled tags to track cannabis products through every stage of the supply chain, from seed to retail sale. Upon deployment Statewide, the program will give regulators and licensees greatly improved visibility into the movement of cannabis goods in California , while making it harder for black-market goods to reach consumers.

Origin House (ORHOF), closed Thursday's trading session at $3.2939, up 1.2262%, on 291,764 volume with 705 trades. The average volume for the last 3 months is 269,300 and the stock's 52-week low/high is $2.5999999/$9.74699974.

chart

Better Choice Company, Inc. (BTTR)

TeleTrader, Stockwatch, TradingView, Street Insider, All Cap Research, Simply Wall St, and Wallet Investor reported beforehand on Better Choice Company, Inc. (BTTR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Better Choice Company, Inc. is an animal health and wellness CBD (cannabidiol) company headquartered in New York, New York. It has acquired TruPet LLC and Bona Vida, Inc. Better Choice Company offers consumers a carefully curated collection of premium pet brands, hemp-derived CBD supplements, and other services that support pet wellness. Better Choice Company lists on the OTC Markets Group’s OTCQB.

The Company’s TruPet is an online seller of ultra-premium, all-natural pet food, treats and supplements. TruPet has a special emphasis on freeze dried and dehydrated raw products. Bona Vida is an inventive emerging CBD platform. Bona Vida’s focus is on developing a portfolio of brand and product verticals within the animal and human health and wellness space.

Better Choice’s vision is to provide clean, holistic, and nutritional options for consumers who want to bring their own healthier lifestyle to their pets. Its products promote wellness and supports better and longer lives for pets.

Better Choice’s portfolio includes TruDog, an online seller of ultra-premium, freeze-dried raw pet food, treats and supplements, and Elvis Presley’s Hound Dog, a unique CBD platform. Additionally, its portfolio includes TruGold, a hemp-based product line, and Rawgo!, a premium dehydrated dog food. The Company’s portfolio also includes Orapup, a dental health system for dogs, TruCat, a premium pet food and supplements brand for cats, and Pet Premium, a leading pet insurance provider.

In October, Better Choice Company announced the signing of a definitive agreement to acquire holistic pet foods leader Halo, Purely for Pets®. The Halo management team, led by branded consumer food and animal health veteran Chief Executive Officer, Mr. Werner von Pein, will continue to manage the Halo business. Halo’s name and brands are not expected to change because of the transaction. The expectation is that the acquisition will close by the end of this year.

Halo® prides itself on the quality of its pet nutrition products using OrigiNative™ GAP and MSC-certified proteins, which say no to factory farming and offer premier digestibility. Halo uses Non-GMO Vegetables in its pet food, which is designed and formulated by an experienced and respected animal nutritionist, and consulted with veterinarians to ensure Halo® continues to offer the best pet food.

Better Choice Company, Inc. (BTTR), closed Thursday's trading session at $1.90, off by 2.0619%, on 15,053 volume with 19 trades. The average volume for the last 3 months is 25,508 and the stock's 52-week low/high is $1.30999994/$13.2600002.

chart

BioXyTran, Inc. (BIXT)

Born2Invest, Wall Street Analyzer, Last10k, Financial Buzz, Proactive Investors, Investors Hangout, TradingView, Stockwatch, Simply Wall St, and Wallet Investor reported earlier on BioXyTran, Inc. (BIXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, BioXyTran, Inc. centers on developing treatments for stroke and Ischemia. An early stage pharmaceutical company, it focuses on the development, manufacture, and commercialization of varied therapeutic drugs to address hypoxia in humans. The Company’s lead pharmaceutical drug candidate is BXT-25. BioXyTran is based in Newton, Massachusetts.

The Company has its BXT-25 and BXT-252. The design of both drugs are to oxygenate ischemic (decreased blood flow) regions of the body and could provide sufferers valuable aid. BXT-25’s co-polymer proprietary chemical structure acts as the chief carrier of oxygen, instead of the red blood cells that are blocked by the clot.

BXT-25 construct substantially reduces methemoglobin formation and nitric oxide scavenging that may contribute to a variety of disorders, including renal failure, vasoconstriction, hypertension, myocardial infarction, and related toxicity issues. Furthermore, BXT-25’s small size, roughly 1/5,000th that of a red blood cell, enables it to perfuse constricted, ischemic capillaries that are inaccessible to red blood cells due to clots or other obstructions.

BXT-25 is based on a new molecule designed to reverse hypoxia in the brain. Hypoxic brain injuries such as ischemic strokes, could be treated with BXT-25 through an intravenous injection that quickly allows the drug molecule to travel to the lungs and bind with the oxygen molecules. From the lungs the molecule mimics a red blood cell traveling to the brain. Since the molecule is 5,000 times smaller than red blood cells, it can penetrate the clot and deliver the oxygen to the critical areas in the brain blocked by the clot.

BXT-25, in testing, will be evaluated as a resuscitative agent to treat strokes, particularly during the all-critical first hour following a stroke. The product will also undergo evaluation for its efficacy in treating other brain trauma issues.

The design of the Company’s BXT-252 is to treat chronic wounds resulting from ischemia caused by occlusion of capillaries. BXT-252 has the same modality and physical properties as BXT-25. Nonetheless, its proprietary co-polymer can improve the healing of pressure and arterial ulcers.

Last week, BioXyTran announced that the Journal Mitochondrion released a peer reviewed article that evaluated a novel way to measure Brain Metabolic Score in real-time using a multiparametric approach to data interpretation. The MDX viewer measures the Tissue Metabolic Score and takes more parameters into account than Brain Metabolic Score.

Animal testing by Professor Mayevsky revealed that the Brain Metabolic Score algorithm is more rudimentary in nature and more heavily skewed toward the NADH Redox state in comparison to the microcirculatory blood flow. The brain was the first of many organs that could be modeled in the future. Animal studies were used by Mayevsky to develop a mathematical model, which fundamentally measures Brain Oxygen Balance. The article, entitled “Mitochondrial Function and Brain Metabolic Score in Ischemic Stroke: Evaluation of “Neuroprotectants” Safety and Efficacy” was published by Prof. Avraham Mayevsky.

BioXyTran, Inc. (BIXT), closed Thursday's trading session at $0.50, even for the day, on 1,500 volume with 3 trades. The average volume for the last 3 months is 5,118 and the stock's 52-week low/high is $0.200000002/$1.95000004.

chart

Flower One Holdings, Inc. (FLOOF)

Cash Crop Today, Pot Stock News, MarketBeat, Street Insider, Invest Tribune, Investing News, Trading View, InvestorsHub, Dividend Investor, Investor Ideas, Stockwatch, Investors Hangout, Stockhouse, and New Cannabis Ventures reported earlier on Flower One Holdings, Inc. (FLOOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Flower One Holdings, Inc. is on the fast track to becoming the foremost cannabis cultivator, producer, as well innovator in Nevada. It owns and operates a 25,000 square-foot cultivation and production facility in North Las Vegas, with nine grow rooms. In addition, the Company owns the established NLV Organics consumer brand of cannabis products. Flower One Holdings is headquartered in Toronto, Ontario. The Company lists on the OTC Markets’ OTCQB.

Flower One is converting its 455,000 square-foot greenhouse and production facility for cultivating and processing high-quality cannabis at scale. This facility is the largest in the State of Nevada. Combined, the flagship greenhouse facility and production facility (upon being totally operational) and the North Las Vegas facility provide the Company with 480,000 square feet of capacity for cultivation and processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

Flower One is completely licensed for medical marijuana cultivation and production, and also recreational marijuana cultivation and production in Nevada. At present, the Company holds licensing agreements with its Brand Partners - Flyte Concentrates, Rapid-Dose Therapeutics' Quick Strip, Old Pal, Palms, HUXTON, CannAmerica Brands, Grenco Science (G Pen), and The Medicine Cabinet.

Last month, Flower One announced its brand partnership with California -born Kiva Confections, bringing their industry-leading, premium cannabis confections to the Nevada marketplace. Kiva's Camino Gummies will be the initial product line to launch in Nevada retailers in 2019. Pairing custom combinations of THC, CBD, and a range of carefully curated terpenes, Camino provides the most tailored cannabis experience on the market.

Kellen O'Keefe , Chief Strategy Officer at Flower One, said, "We are thrilled to announce the addition of Kiva Confections – California's leading edible brand – to Flower One's growing portfolio of Brand Partners. Kiva's built an industry-leading, premium brand focused on quality and consistency. Their delicious, low-dose options and unique formulations will make excellent additions to Nevada's growing variety of exceptional cannabis products."

Flower One Holdings, Inc. (FLOOF), closed Thursday's trading session at $0.59, up 11.5312%, on 211,531 volume with 117 trades. The average volume for the last 3 months is 112,969 and the stock's 52-week low/high is $0.50/$2.80999994.

chart

STWC Holdings, Inc. (STWC)

CannabisFN, StocksBeat, All Stocks Today, Street Insider, PotNetwork, Cannabis Dispensary, OTC Markets, Cannabis Business Times, Invest Tribune, Stock Target Advisor, Real Investment Advice, OTC.Watch, InvestorsHub, Simply Wall St, Stockhouse, 4-Traders, and Seeking Alpha reported earlier on STWC Holdings, Inc. (STWC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

STWC Holdings, Inc. is a foremost cannabis consultant and industry pioneer listed on the OTC Markets Group’s OTCQB. It offers a wide-ranging ecosystem of entities and services, which support the expanding cannabis industry. Established in 2012, the Company was previously known as Strainwise, Inc. It changed its name to STWC Holdings, Inc. in June of 2016. STWC has its corporate office in Lakewood, Colorado.

The Company offers capital, strategic partnership, and seed-to-sale consulting. It also offers design, marketing and advertising services. STWC provides its partners access to its complete suite of assets. It develops made-to-order solutions to address the range of challenges that cannabis entrepreneurs and businesses face.

SquareOne™ is the Company’s 3-phase consulting platform. It assists cannabis entrepreneurs in launching their new businesses successfully - with measurable results. With SquareOne™, STWC is able to deliver concise consulting services to cannabis entrepreneurs. The SquareOne™ consulting platform guides clients in understanding the financial dimensions and market conditions in their respective jurisdictions.

This past April, STWC Holdings announced that it executed a joint venture (JV) for the development of an innovative software package customized for the cannabis industry. The agreement with Dana Ress of Denver’s RedPoint Solutions will result in a software solution named Supergrower, targeted for July, which will address the complexities of conducting business in the arena of legal marijuana, with functionality across all four cannabis verticals: cultivation, manufacturing, distribution and retail.

STWC Holdings Chief Executive Officer, Erin Phillips, said, “After working with hundreds of operators in the cannabis industry, we realized that most operators are looking for powerful tools to manage their day-to-day operations and plan for the future. As cannabis businesses continue to evolve and mature, this issue will become increasingly insurmountable. Supergrower will provide the business analytics necessary for an operator to thrive in today’s cannabis industry.”

Under the JV, STWC Holdings and Ress will work together to develop an efficient and scalable software platform. It will be the first complete management system for the cannabis industry. The design of the Supergrower platform, an SaaS product, is to operate across all standalone software, aggregating data, performing analytics, and providing valuable insights to customers through customizable reports and dashboards.

STWC Holdings, Inc. (STWC), closed Thursday's trading session at $0.05, up 100.00%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 4,328 and the stock's 52-week low/high is $0.025/$2.00.

chart

Novo Integrated Sciences, Inc. (NVOS)

Tip Ranks, Morningstar, YCharts, Trading View, Last10k, Barchart, Simply Wall St, Wallet Investor, Stockhouse, MarketWatch, Equity Clock, The Street, and GuruFocus reported earlier on Novo Integrated Sciences, Inc. (NVOS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc., via Novo Healthnet Limited, delivers multi-disciplinary primary healthcare to greater than 400,000 patients annually. The Company does so by way of its 15 corporate-owned clinics and a contracted network of 97 affiliate clinics and 222 eldercare centric homes located throughout Canada. Novo Integrated Sciences is headquartered in Bellevue, Washington and the Company lists on the OTCQB.

Novo continues to build its health science platform of services and products via the integration of technology and rehabilitative science. One element of the Company’s lateral business growth strategy includes developing business units focused on the direct control of the grow, extraction, manufacturing and distribution processes for hemp and medical cannabidiol products.

Novo Integrated Sciences continues to expand on its patient care philosophy of maintaining a continuing connection with its patient community through extending oversight of patient diagnosis, care and monitoring, directly into the patient’s home, by way of different mobile telemedicine and diagnostic tools.

Novo’s specialized services and products include physiotherapy, chiropractic care, chiropody, occupational therapy, eldercare, laser therapeutics, and massage therapy. Services and products additionally include acupuncture, neurological functions, kinesiology, concussion management and baseline testing, women's pelvic health, sports medicine therapy, assistive devices and private personal training. The Company does not provide primary care medical services. Moreover, none of its employees practices primary care medicine. In addition, its services do not necessitate a medical or nursing license.

Recently, Novo Integrated Sciences, Inc. and Novo Healthnet Limited (NHL), a wholly-owned subsidiary of Novo Integrated Sciences, announced the signing of a definitive Share Purchase and Exchange Agreement (SPEA), dated February 20, 2019, with Pulse Rx, Inc. and with the shareholders of Pulse Rx. Pulse Rx is a private Canadian limited company operating as Pulse Rx LTC Pharmacy. Pulse Rx provides pharmacy services to long-term care and retirement residences in the Province of Ontario.

Mr. Robert Mattacchione, Novo Integrated Sciences’ Chief Executive Officer and Board Chairman, stated, “The addition of Pulse Rx to our Canadian healthcare holdings represents the continued manifestation of our lateral growth objectives. The synergy of this acquisition will be felt across several existing NHL business silos with the most immediate impact being to our eldercare division and its ability to offer a more comprehensive array of core products and services across an expanding geriatric demographic.”

Recently, Novo Integrated Sciences and Novo Healthnet Limited (NHL) announced the signing of an exclusive Licensing Agreement with Cloud DX, Inc. Cloud DX is an award-winning medical device company, operating in the U.S. and Canada. It develops hardware and related software for Remote Patient Monitoring and Chronic Care Management.

This Licensing Agreement provides NHL with perpetual licensing rights to the Bundled Pulsewave PAD-1A USB Blood Pressure Device, related software and up-to-date product releases. Moreover, the License Agreement provides NHL with conditional exclusive rights, over the initial 5-year period, to sub-license and re-sell Bundled Pulsewave Devices and related software.

Novo Integrated Sciences, Inc. (NVOS), closed Thursday's trading session at $0.70, up 55.5556%, on 9,326 volume with 7 trades. The average volume for the last 3 months is 4,877 and the stock's 52-week low/high is $0.109999999/$2.3499999.

chart

Brightlane Corp. (BTLN)

OTC Markets, Penny Stock Tweets, Market Exclusive, TradingView, Marketwired, Simply Wall St, Stockhouse, Barchart, 4-Traders, Morningstar, GuruFocus, MarketWatch, InvestorsHub, Capital Cube, YCharts, and Infront Analytics reported earlier on Brightlane Corp. (BTLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Brightlane Corp. is a real estate operating company listed on the OTC Markets. It provides an alternative corridor to home ownership via a right-to-purchase program after meeting certain criteria. The Company focuses on acquiring, renovating, managing, and leasing low priced single-family homes chiefly in the United States. Brightlane has its corporate headquarters in Houston, Texas. The Company has its Operations Office in Atlanta, Georgia.

Brightlane’s acquisition efforts are primarily centered in the Southeast, Midwest, and Southwest regions of the United States. Its acquisition strategy is centered on multi-family housing - serving markets that include active senior living and Class A student housing. The Company is looking to expand its service offerings by way of acquisition and property management enhancement.

Brightlane provides opportunities in the affordable housing market. This includes reasonable rents and leases. At present, the Company acquires single-family homes and portfolios of single-family homes. It pursues the acquisition of these kinds of homes via one-off purchases, the purchase of portfolios, as well as other methods of acquisition.

Brightlane is looking for growth in ancillary markets. The Company is enhancing its business plan to access higher value and higher profit market segments with synergistic effects to its business model. It is working to expand its business model into different areas. These areas include multifamily, and the above-mentioned active adult living, and student housing.

Additionally, these areas include build-to-rent in the affordable housing space, non-performing notes, as well as credit reporting. Brightlane will also execute a ground up construction platform of rental single and multifamily products.

The Company announced in June 2018 that it reinforced its plans to expand its core technology development through the exploration of acquisition opportunities to further enhance its unique property value management services. The move will help to expedite the development of Brightlane’s proprietary, cloud-based platform to simultaneously manage single family, multifamily and student housing property operations.

This past July, Brightlane announced the launch of its newly redesigned website (brightlanecorp.com) as part of a brand refresh campaign started by the Company early this year. The Company stated that the new website is well positioned as a foremost source for insights, solutions, and interactive features for the property management industry. The new site has been optimized to ensure visitors are provided a premier user experience across all digital devices.

Brightlane Corp. (BTLN), closed Thursday's trading session at $0.20, up 308.1633%, on 460,372 volume with 201 trades. The average volume for the last 3 months is 1,683 and the stock's 52-week low/high is $0.045000001/$0.75.

chart

AbraPlata Resource Corp. (ABBRF)

NetworkNewsWire, Stockwatch, Market Screener, Resource Stock Digest, Junior Mining Network, Gold Stock Data, Trading View, Private Capital Newswire, Gold Silver Metals, The News Wire, Simply Wall St, Stockhouse, 4-Traders, Barchart, WalletInvestor, and Miners and Investors reported previously on AbraPlata Resource Corp. (ABBRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AbraPlata Resource Corp. concentrates on delivering shareholder returns through unlocking mineral value in Argentina. It has a first-class portfolio of gold, silver and copper exploration assets. A junior mining exploration company, AbraPlata Resource is centered on advancing its flagship Diablillos silver-gold property. OTCQB-listed, the Company has its corporate office in Vancouver, British Columbia.

The flagship Diablillos silver-gold property has an Indicated Mineral Resource containing 80.9M oz Ag and 732k oz Au, through the different stages of feasibility. In addition, AbraPlata Resource owns the highly prospective Cerro Amarillo property, which has a cluster of five mineralized Cu-(Mo-Au) porphyry intrusions. The Cerro Amarillo property is positioned in a mining camp hosting the huge El Teniente, Los Bronces, and Los Pelambres porphyry Cu-Mo deposits.

In March 2018, AbraPlata announced that it tabled a positive Preliminary Economic Assessment (PEA) on its 80 sq. km Diablillos silver-gold project in Argentina’s Salta Province. The PEA features robust economics, with an after-tax Net Present Value (NPV) of US$197 million at a 7.5 percent discount rate, an after-Tax Internal Rate of Return (IRR) of 30.2 percent, and a 3-year pay-back. AbraPlata Resource stated that the project could produce 9.8 million oz. of silver equivalent each year at an all-in sustaining cost of US$7.52 per oz. silver equivalent.

AbraPlata Resource announced this past April the filing on SEDAR of the PEA Technical Report for its Diablillos silver-gold project. The Report is entitled "Technical Report on the Diablillos Project, Salta Province". It is dated April 16, 2018. The Report proposes that open pit mining be carried out by contractor as a conventional truck and shovel operation on two pits at Diablillos. These are the larger Oculto pit and the smaller Fantasma open cut. AbraPlata said that 95 percent of its resource comes from Oculto. However, it still has several satellite deposits it is in the process of drilling.

This past August, AbraPlata Resource announced an update on its Diablillos property in northwestern Argentina. AbraPlata has been conducting a review of historical drill data to ascertain if higher grade silver and gold zones could potentially be exploited utilizing underground mining methods. An underground mining approach could entail considerably less initial capital than the large open pit approach contemplated in the Company's 2018 PEA on the Diablillos project.

The comprehensive drill database review by AbraPlata Resource follows the identification by Mr. Nick Tate, AbraPlata's consulting geologist and epithermal specialist, that high grade mineralized cores are strongly correlated with steeply dipping, tabular hydrothermal breccia bodies in the main Oculto deposit. Historical drilling that totals approximately 88,000m in 450 drill holes, intercepted these breccias in manifold drill holes with the best mineralization being encountered at the intersection of the Main Breccia Zone and the Cross Breccia Zone.

AbraPlata Resource Corp. (ABBRF), closed Thursday's trading session at $0.0445, up 41.2698%, on 4,999 volume with 2 trades. The average volume for the last 3 months is 26,042 and the stock's 52-week low/high is $0.028/$0.077600002.

chart

Vilacto Bio,  Inc. (VIBI)

OTC Markets and The Street reported on Vilacto Bio,  Inc. (VIBI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vilacto Bio,  Inc.  is a biotechnology company listed on the OTCQB. It has developed the now fully patented Lactoactive® (Lactoactive molecule). In numerous studies, Lactoactive® has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. At present the Company’s products are available on the market as Vilact®.

Founded in 2013, Vilacto Bio is headquartered in New York, New York. The Company previously went by the name Zlato, Inc. It changed its name to Vilacto Bio, Inc. on April 4, 2017. The Company’s European Headquarters are in Næstved, Denmark. Its Research and Development (R&D) operations are in Lithuania.

Vilacto Bio’s goal is to be the leading biotechnology company centered on commercializing unique pharmaceutical cosmeceutical products formulated or reformulated with Lactoactive® as nanoparticle according to its patented properties.  The Company’s aim is to further develop its Lactoactive® molecule for increasing the quality of its retail and medical skin cream products, as well as licensing out its Lactoactive® molecule for the pharmaceutical industry.

Lactoactive® is highly refined colostrum, developed to provide first-rate results for people needing healing or relief from a range of skin issues. Lactoactive® is a refined processing of colostrum combined with hyaluronic acid. Proteins in Vilact® survive longer without being degraded by enzymes. This enables them to work longer in the skin. 

Vilacto Bio has its Vilact Cuticle cream product, developed in cooperation with Danish podiatrists. Lactoactive, the ingredient molecule in Vilact Cuticle cream, works to help with skin challenges. Danish podiatrists have demonstrated its use with faster patient recovery.

This past January, Vilacto Bio announced that it started development of the Vilacto Bio Skincare Knowledge Center. This is an online resource that will gather skincare knowledge, science, insights and tips from scientists, dermatologists, podiatrists and other specialists around the world.

The tips and guides presented in the Vilacto Bio Knowledge Center will be shared with industry magazines internationally, and also with Vilacto customers. The expectation is that the Vilacto Bio Knowledge Center will enhance dialogue among specialists and consumers, improve outcomes, and drive higher traffic to Vilacto Bio’s commercial web portal.

Vilacto Bio,  Inc. (VIBI), closed Thursday's trading session at $0.0001, up 100.00%, on 3,120,000 volume with 8 trades. The average volume for the last 3 months is 40,754,380 and the stock's 52-week low/high is $0.000000999/$0.079000003.

chart

StartMonday Technology Corp. (STMDF)

Dividend Investor, OTC Markets, Stockhouse, MarketWatch, Barchart, GuruFocus, Science of Stocks, Investorx.ca, and Penny Stock Hub reported on StartMonday Technology Corp. (STMDF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

StartMonday Technology Corp. engages in candidate selection solutions for employers in the retail and hospitality sectors. The Company helps employers choose better candidates, quicker, with the power of 15-second video introductions. A smart recruitment technology enterprise, StartMonday Technology has its corporate headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

StartMonday Technology was founded by professionals from the recruiting and tech fields - Ray Gibson from recruiting and HR, and Andrew Evans from the founding team at Careerbuilder.com.

StartMonday Technology’s commitment is to building strong tools for the Mobile Generation. Moreover, the Company is further developing its technology with an open blockchain solution for verifiable career histories named CareerChain.

StartMonday's video-led mobile and web applications deliver a better impression of customer skills and personality, ultimately assisting employers in deciding which candidates they should talk to first. This makes the process much more efficient.

StartMonday's core products center around 15-second videos filmed by candidates on their own mobile phones and web browsers. This puts job applications decisively in the social media and mobile native arena.

This enables job seekers to present themselves in their own way. In addition to lessening cost and time-to-hire, the Company brings massive employer branding opportunities to its clients.

Recently, StartMonday Technology announced that it has partnered with Talent Tech Labs (TTL)- Manhattan-based, as part of their late-stage accelerator program targeted at advancing select, mature startups ready for targeted penetration into the North American market. Talent Tech Labs is a sector leader in the knowledge and analysis of up-and-coming trends and technologies applied to improving the state of the art of recruitment.

StartMonday Co-Founder and Chief Executive Officer, Mr. Ray Gibson said, “We are extremely pleased to have been selected for the TTL accelerator program. This is a limited and very influential opportunity that has previously proven its worth at propelling entry into the U.S. marketplace… We believe this program will ideally position us to really show what StartMonday and CareerChain can do to accelerate success within the HR industry arm of Corporate America.”

StartMonday Technology Corp. (STMDF), closed Thursday's trading session at $0.0399, up 418.1818%, on 300 volume with 2 trades. The average volume for the last 3 months is 2,158 and the stock's 52-week low/high is $0.00755/$0.100000001.

chart

Enertopia Corp. (ENRT)

Penny Stock General, Shiznit Stocks, Cannabis Financial Network News, PennyStocks24, Fast Money Alerts, Stock Shock and Awe, Penny Champions, Equities.com, MassiveStockProfits, Wall Street Equities Research, Stockgoodies, GrowthPennyStocks, and Penny Dreamers reported earlier on Enertopia Corp. (ENRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Enertopia Corp. is exploring a portfolio of three prospective lithium projects in the State of Nevada. Additionally, at the same time, the Company is working with water purification technology believed to be able to recover Lithium from brine solutions. Enertopia has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.

In June 2017, Enertopia announced its Surface Exploration Program in Nevada. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.

The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.

Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.

Since September 2017, GWT has been evaluating data obtained from the first bench test results and other technical data provided by Enertopia to complete a larger and enhanced lithium recovery system. This $200,000 pre-paid second phase bench test is now complete. The second phase of the second bench test will use synthetic brine solutions, which will be created from the surface samples from the two bulk samples taken at Enertopia’s Clayton Valley project.

The next steps for the Company in 2018 are a bench test build out this month and preparation of synthetic brines in February. In March and April, bench testing of synthetic lithium brines will take place. In May will be final laboratory lithium recovery and Li2CO3 grade results.

Enertopia Corp.  (ENRT), closed Thursday's trading session at $0.0068, up 44.6809%, on 10,672 volume with 5 trades. The average volume for the last 3 months is 32,047 and the stock's 52-week low/high is $0.0041/$0.035.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted today in a publication from Motley Fool, examining how the big day that we've all been waiting for is nearly here in Canada. Following the commencement of recreational cannabis sales on Oct. 17, 2018, and the implementation of regulations regarding marijuana derivatives exactly one year later (Oct. 17, 2019), we're now just days away from these alternative consumption options officially hitting dispensary shelves.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $2.57, up 0.390625%, on 2,808,796 volume with 8,281 trades. The average volume for the last 3 months is 2,419,473 and the stock's 52-week low/high is $2.00/$8.43999958.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) board of directors. To view the full press release, visit http://nnw.fm/U9Lje.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $0.9258, up 1.301%, on 184,520 volume with 166 trades. The average volume for the last 3 months is 146,097 and the stock's 52-week low/high is $0.779999971/$4.7800002.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/6F87x.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Thursday's trading session at $1.08, up 4.8544%, on 73,752 volume with 129 trades. The average volume for the last 3 months is 188,668 and the stock's 52-week low/high is $0.451099991/$2.46000003.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced the launch of Sugarleaf by 7AC ("Sugarleaf"). According to the update, Sugarleaf is Supreme Cannabis' newest introduction of high-quality cannabis experiences to the Canadian marketplace and widens the company's product offerings, targeting consumers who demand a more refined, milder consumption experience. To view the full press release, visit http://cnw.fm/N0fwP. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Fifty year old Ingrid Martinez is terminally ill and undergoing chemotherapy. Martinez uses medical marijuana to manage pain and nausea. She resides in Lowell, and before she got sick, she was working in medical coding. Martinez travels to Maine after every three weeks to buy marijuana rather than get her supplies from Massachusetts where she resides. Additionally, the company was highlighted in a publication from MarijuanaStocks.com, explain that Supreme Cannabis Company looks like it has a solid grasp on its niche market. Additionally, the company has managed to forgo a large amount of the market volatility due to it being a part of a smaller subset of the industry. Notwithstanding its size, the company remains one of the most intriguing marijuana stocks to watch.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.4966, up 3.4583%, on 309,838 volume with 197 trades. The average volume for the last 3 months is 545,682 and the stock's 52-week low/high is $0.432000011/$1.7888.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC), a science forward company developing unique hemp and cannabinoid infusion technologies, today announced the filing of a patent on a new hemp extract and cannabinoid delivery system for food and beverages. According to the update, the technology enables utilization of very small amounts of extracts in formulations in order to produce similar or superior results compared to other infusions. To view the full press release, visit http://cnw.fm/E8dA0.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Thursday's trading session at $0.48, up 23.0769%, on 2,100 volume with 6 trades. The average volume for the last 3 months is 12,621 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

chart

Grapefruit Boulevard Investments Inc. (IGNG)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit Boulevard Investments Inc., the wholly owned subsidiary of Imaging3 Inc. (IGNG).

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that the company entered into a weekly purchase agreement on Friday, December 6, 2019. Per the agreement, IGNG will supply “fresh-frozen” cannabis flowers to a sizeable, Oakland, California-based cannabis extractor and manufacturer. To view the full press release, visit http://cnw.fm/bY2Ue.

Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.

The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.

Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.

Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.

Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.

The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.

Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.

The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.

Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.

Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.

Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.

Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:

  • Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
  • Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.

Grapefruit Boulevard Investments Inc. (IGNG), closed Thursday's trading session at $0.075, up 7.1429%, on 262,316 volume with 28 trades. The average volume for the last 3 months is 196,497 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (SING) was featured today in a publication from Investorideas.com. A special report looking at some of the recent developments between the tobacco and CBD/hemp industry, including the recent deal with SinglePoint Inc. (OTCQB:SING) and global tobacco company, JTI USA. https://www.jti.com/about-us.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.01, up 9.8901%, on 4,605,297 volume with 130 trades. The average volume for the last 3 months is 4,005,297 and the stock's 52-week low/high is $0.008299999/$0.028799999.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its CEO, Warren Wang, is featured in a new audio interview at SmallCapVoice.com (http://cnw.fm/1Y0nA). To view the full press release, visit http://cnw.fm/d5CrO. Also today, the company was highlighted in a publication from CBDWire, examining how CIIX has become a top financial-information website for Chinese-speaking investors in the United States and China. At the heart of the approach is the ChineseInvestors Method, an inventive integration of a disciplined investing process, web-based tools, personalized instructions and support. In addition, the company is working to capitalize on the increasing demand for CBD (cannabidiol)-based nutrition and health products.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.2, even for the day, on 74,392 volume with 21 trades. The average volume for the last 3 months is 45,918 and the stock's 52-week low/high is $0.165000006/$0.654999971.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

The power of artificial intelligence (AI) to assist in the detection of ovarian cancer much earlier than previously possible is being recognized worldwide. A company in the United Kingdom is touting the ability of AI to eliminate late detection of ovarian cancer, thanks to advancements in health-care technology (http://nnw.fm/beR20). The contribution AI is making in the detection of ovarian cancer has been a longtime, consistent focus for Predictive Oncology Inc. (NASDAQ: POAI) as well.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Thursday's trading session at $2.72, off by 4.5614%, on 46,683 volume with 183 trades. The average volume for the last 3 months is 41,925 and the stock's 52-week low/high is $2.3499999/$8.50.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group, Inc. (OTCQB:TRXD) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/xJkH2.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Thursday's trading session at $1.25, off by 10.7143%, on 12,223 volume with 12 trades. The average volume for the last 3 months is 3,317 and the stock's 52-week low/high is $0.230000004/$1.60000002.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted in a publication from Financialnewsmedia.com, examining how cannabis could very well be the hottest buzzword of 2020.  For one, we’re just beginning to see higher approval ratings for cannabis in the U.S.  According to the Pew Research Center, 67% of Americans now support its legalization  In addition, only 32% of adults now oppose legalization, as compared to 52% in 2010.  Two, many more retailers are jumping on board.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $0.64, off by 6.9903%, on 623,776 volume with 392 trades. The average volume for the last 3 months is 256,425 and the stock's 52-week low/high is $0.620000004/$5.20499992.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, this morning announced that it has granted, effective today, an aggregate of 3,364,500 stock options (each, an "Option") to certain directors, officers, employees and consultants of the company in accordance with the company's stock option plan. To view the full press release, visit http://cnw.fm/krE4C.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Thursday's trading session at $0.1569, off by 3.1481%, on 180,647 volume with 78 trades. The average volume for the last 3 months is 126,389 and the stock's 52-week low/high is $0.150000005/$0.930000007.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading, single-source provider of next-generation communications network, technology, infrastructure and maintenance solutions, recently acquired global battery technology company WaveTech GmbH. To view the full article, visit http://nnw.fm/xy3dT.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Thursday's trading session at $0.0285, off by 8.0645%, on 56,398 volume with 10 trades. The average volume for the last 3 months is 114,024 and the stock's 52-week low/high is $0.014999999/$0.349999994.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders (OTC: NBDR) today announced its addition of Stefan Lloyd as its newest member of the Strategic Advisory Board. Stefan, a globally renowned finance professional, sits on the Advisory Board of Ekap Aif, a Swedish venture capital firm as well as the Swedish American Chamber of Commerce in Texas and previously at the Institute for Innovation and Entrepreneurship at the University of Texas at Dallas. To view the full press release, visit http://ccw.fm/ZcV7j. Also today, the company was highlighted in a publication from HempWireNews. You have probably heard of hemp, or maybe you know it as cannabis. Dubbed industrial hemp because of its numerous industrial applications, it has proven one of the most versatile and profitable cash crops of the century.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Thursday's trading session at $0.017, off by 10.9948%, on 218,758 volume with 8 trades. The average volume for the last 3 months is 66,828 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.